← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Verantos, Inc.
Menlo Park, CA
$8,732,506
Total funding
3
Grants
Funding over time
peak $3.6M · FY2018–22$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
Funding mix
By agency
FDA$5,686,200 · 1
NSF$1,697,077 · 1
NIH$1,349,229 · 1
By mechanism
U01$5,686,200 · 1
—$1,697,077 · 1
R44$1,349,229 · 1
Investigators at Verantos, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)$1,895,400
U01 · FY2022 · FD
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)$1,895,400
U01 · FY2020 · FD
Transforming Real-world evidence with Unstructured and Structured data to advance Tailored therapy (TRUST)$1,895,400
U01 · FY2021 · FD
SBIR Phase II: Determination of complex outcome measures using narrative clinical data to enable observational trials$1,697,077
· FY2021 · TIP
Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare$749,614
R44 · FY2019 · TR
Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare$599,615
R44 · FY2018 · TR